To address whether CD133- cells can be converted to CD133+ tumor cells without adding exogenous TGF-β, and if so, whether mTOR signaling is involved in the process, we employed a single-cell long-term culture system (Figure 4A). This evidence concerns the gene TGFB1 and neoplasm.